GTB-3550
GT Biopharma
[]
$gtbp - gt biopharma presents preclinical data demonstrating second-generation cd19 targeting tri-specific killer engager (trike ) driving robust nk cell function against b cell malignancies at eha 2022 congress 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.